Nephros/$NEPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Nephros
Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of revenue from product sales and a small amount from royalty revenue and other revenues.
Ticker
$NEPH
Sector
Primary listing
Employees
36
Headquarters
Website
Nephros Metrics
BasicAdvanced
$32M
26.91
$0.11
1.48
-
Price and volume
Market cap
$32M
Beta
1.48
52-week high
$6.42
52-week low
$1.64
Average daily volume
42K
Financial strength
Current ratio
4.056
Quick ratio
2.824
Long term debt to equity
6.587
Total debt to equity
10.42
Interest coverage (TTM)
1,146.00%
Profitability
EBITDA (TTM)
1.285
Gross margin (TTM)
61.87%
Net profit margin (TTM)
6.35%
Operating margin (TTM)
6.10%
Effective tax rate (TTM)
1.00%
Revenue per employee (TTM)
$520,000
Management effectiveness
Return on assets (TTM)
5.76%
Return on equity (TTM)
12.71%
Valuation
Price to earnings (TTM)
26.909
Price to revenue (TTM)
1.672
Price to book
3.09
Price to tangible book (TTM)
3.52
Price to free cash flow (TTM)
19.096
Free cash flow yield (TTM)
5.24%
Free cash flow per share (TTM)
0.155
Growth
Revenue change (TTM)
32.67%
Earnings per share change (TTM)
1,464.72%
3-year revenue growth (CAGR)
23.50%
10-year revenue growth (CAGR)
25.46%
3-year earnings per share growth (CAGR)
-46.79%
10-year earnings per share growth (CAGR)
-18.18%
Nephros News
AllArticlesVideos
�Nephros Expands Water Safety Capabilities With ASSE 12080 Certified Water Management Planning Expertise
MCAP MediaWire·2 weeks ago
�Nephros Announces Fourth Quarter and Record Fiscal Year 2025 Financial Results
MCAP MediaWire·1 month ago
�Nephros Schedules Fourth Quarter 2025 Financial Results Conference Call
MCAP MediaWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Nephros stock?
Nephros (NEPH) has a market cap of $32M as of April 13, 2026.
What is the P/E ratio for Nephros stock?
The price to earnings (P/E) ratio for Nephros (NEPH) stock is 26.91 as of April 13, 2026.
Does Nephros stock pay dividends?
No, Nephros (NEPH) stock does not pay dividends to its shareholders as of April 13, 2026.
When is the next Nephros dividend payment date?
Nephros (NEPH) stock does not pay dividends to its shareholders.
What is the beta indicator for Nephros?
Nephros (NEPH) has a beta rating of 1.48. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.